Epigenetic inactivation of the potential tumor suppressor gene FOXF1 in breast cancer.
about
Forkhead transcription factor FoxF1 interacts with Fanconi anemia protein complexes to promote DNA damage responseGenetic polymorphisms are associated with the risk of gastric and colorectal cancers in a Han Chinese population.MeCP2 Promotes Gastric Cancer Progression Through Regulating FOXF1/Wnt5a/β-Catenin and MYOD1/Caspase-3 Signaling Pathways.FOXF1 mediates mesenchymal stem cell fusion-induced reprogramming of lung cancer cellsDecreased FOXF2 mRNA expression indicates early-onset metastasis and poor prognosis for breast cancer patients with histological grade II tumor.Breast cancer methylomes establish an epigenomic foundation for metastasis.Comparative analyses of lung transcriptomes in patients with alveolar capillary dysplasia with misalignment of pulmonary veins and in foxf1 heterozygous knockout miceMolecular and clinical analyses of 16q24.1 duplications involving FOXF1 identify an evolutionarily unstable large minisatelliteThe p53-p21WAF1 checkpoint pathway plays a protective role in preventing DNA rereplication induced by abrogation of FOXF1 functionA 16q deletion involving FOXF1 enhancer is associated to pulmonary capillary hemangiomatosis.Forkhead Box F1 promotes breast cancer cell migration by upregulating lysyl oxidase and suppressing Smad2/3 signalingSmall noncoding differentially methylated copy-number variants, including lncRNA genes, cause a lethal lung developmental disorder.Cytoplasmic mislocalization of overexpressed FOXF1 is associated with the malignancy and metastasis of colorectal adenocarcinomasIdentical effects of VEGF and serum-deprivation on phenotype and function of adipose-derived stromal cells from healthy donors and patients with ischemic heart diseaseLethal lung hypoplasia and vascular defects in mice with conditional Foxf1 overexpression.Decreased expression of FOXF2 as new predictor of poor prognosis in stage I non-small cell lung cancer.Loss of FOXF2 Expression Predicts Poor Prognosis in Hepatocellular Carcinoma Patients.FOXF2 promoter methylation is associated with prognosis in esophageal squamous cell carcinoma.Forkhead transcription factor FOXF1 is a novel target gene of the p53 family and regulates cancer cell migration and invasiveness.Epigenetic alteration of CCDC67 and its tumor suppressor function in gastric cancer.Overexpression of forkhead box J2 can decrease the migration of breast cancer cells.Decreased FOXF1 promotes hepatocellular carcinoma tumorigenesis, invasion, and stemness and is associated with poor clinical outcome.Aberrant DNA methylation and tumor suppressive activity of the EBF3 gene in gastric carcinoma.A urinary microRNA signature can predict the presence of bladder urothelial carcinoma in patients undergoing surveillance.BRAF mutation-specific promoter methylation of FOX genes in colorectal cancerThe Emerging Roles of Forkhead Box (FOX) Proteins in Osteosarcoma.The dual role of FOXF2 in regulation of DNA replication and the epithelial-mesenchymal transition in breast cancer progressionGenomic and Epigenetic Complexity of the FOXF1 Locus in 16q24.1: Implications for Development and Disease.FoxF1 and FoxF2 transcription factors synergistically promote rhabdomyosarcoma carcinogenesis by repressing transcription of p21Cip1 CDK inhibitor.HOXC10 Expression Supports the Development of Chemotherapy Resistance by Fine Tuning DNA Repair in Breast Cancer Cells.Expression of Bmi1, FoxF1, Nanog, and γ-catenin in relation to hedgehog signaling pathway in human non-small-cell lung cancer.Prognostic impact of FOXF1 polymorphisms in gastric cancer patients.Antisense lncRNA FOXF1-AS1 Promotes Migration and Invasion of Osteosarcoma Cells Through the FOXF1/MMP-2/-9 Pathway.Forkhead Box F1 represses cell growth and inhibits COL1 and ARPC2 expression in lung fibroblasts in vitro.The transcription factor FOXF1 promotes prostate cancer by stimulating the mitogen-activated protein kinase ERK5.Down syndrome associated childhood myeloid leukemia with yet unreported acquired chromosomal abnormalities and a new potential adverse marker: dup(1)(q25q44).Epigenetic Downregulation and Growth Inhibition of IGFBP7 in Gastric CancerFOXF1 Induces Epithelial-Mesenchymal Transition in Colorectal Cancer Metastasis by Transcriptionally Activating SNAI1
P2860
Q28270475-8A12D582-C685-43B2-A330-77A44C5096AFQ33709900-26C3C0A9-C844-482C-B31F-9F882330A664Q33809732-5D6CE113-BA6C-414A-8D25-279B4FED9FBBQ34619436-65EEA37C-03CA-4F87-9FEB-0D4E73B72F15Q34689061-F17F6ABD-C8A0-422F-A22F-87566B0D065AQ35136051-BEE699FB-871C-467D-8E45-C221A2A62A0FQ35144975-A648A199-68F1-4C69-8E25-2213E938520BQ35486982-C8D858F1-CF58-47AF-93D8-4DC41D9C6AACQ35488978-C3BC2E78-116C-49AA-B419-40526827031FQ35805104-3F81D0B3-DFE4-4D82-A9C1-AE22DABB8AB7Q35933347-7CE84511-7863-491F-BAFE-74D3CB76C254Q36490015-C41BF4D2-1425-4ADB-B882-E94AA4FDD350Q36581878-98CA2B28-D3A7-4BFA-ACE7-60108865639CQ37367626-E50BF62D-A551-4C66-B4A5-1D1EBE22291DQ37502184-DFDF306D-F91D-4237-9CD4-7234D5F9F19FQ37688280-B60D73EA-968E-4449-B4E6-F704ADE9C0A2Q38893002-C04F74F6-238A-43FF-B260-37CBCF1BB760Q38949791-4B128761-1446-46E3-8C85-8FAC43869B0CQ39067507-F55F4E72-4D5F-43A3-A702-F445922912DAQ39345572-6167721B-6AB4-4833-A441-CFCF29AFCC66Q39375100-69721FE1-B34E-4D17-9BEE-5D3C27AAAE28Q39556002-D1B7E25A-DDDF-4FF4-B702-AB8FB8304525Q39579086-53BDAB2A-8144-47D3-B005-0E8493EE7EC4Q39734525-FF6AE6E0-2EED-47AD-8C14-2B4973B62799Q41056167-A0621723-A378-46FB-8A55-A07A1131F354Q41180209-D5D284EE-5CC8-431E-A20A-05D6F8AF38A9Q41637093-EA38831F-43E8-492C-9D5F-AC43F5708FCCQ41826361-1BBD89AD-18EE-4ABF-A512-4DA3642C5719Q42329883-914B88F6-842B-40CB-B670-BEE76436EC19Q42385396-9DC1CC39-6CFB-40B5-B7C8-ED8019698EBAQ46692334-D3E7F4A6-A455-4B28-ADDE-FAD2ED15B6E3Q46923415-F18A3D50-8E0E-4DE0-A2A6-41736877E657Q47098805-05642278-00C9-477C-8A41-42B5609837E9Q47741187-374780D6-BE29-4E6F-A882-D1A345B155C0Q51337382-1741ED0B-C1CD-4DA6-87D4-1A38D3606E44Q52643638-AD0D33F9-7640-4236-9488-64CC3B5D5140Q55223525-E2BBD227-3071-4F0D-BB7D-E71BDE83382DQ58754959-FA0A6288-8320-461F-B0B1-FFDC718CD25A
P2860
Epigenetic inactivation of the potential tumor suppressor gene FOXF1 in breast cancer.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Epigenetic inactivation of the potential tumor suppressor gene FOXF1 in breast cancer.
@ast
Epigenetic inactivation of the potential tumor suppressor gene FOXF1 in breast cancer.
@en
Epigenetic inactivation of the potential tumor suppressor gene FOXF1 in breast cancer.
@nl
type
label
Epigenetic inactivation of the potential tumor suppressor gene FOXF1 in breast cancer.
@ast
Epigenetic inactivation of the potential tumor suppressor gene FOXF1 in breast cancer.
@en
Epigenetic inactivation of the potential tumor suppressor gene FOXF1 in breast cancer.
@nl
prefLabel
Epigenetic inactivation of the potential tumor suppressor gene FOXF1 in breast cancer.
@ast
Epigenetic inactivation of the potential tumor suppressor gene FOXF1 in breast cancer.
@en
Epigenetic inactivation of the potential tumor suppressor gene FOXF1 in breast cancer.
@nl
P2093
P2860
P1433
P1476
Epigenetic inactivation of the potential tumor suppressor gene FOXF1 in breast cancer.
@en
P2093
Helen Sadik
Ji Shin Lee
Liangfeng Han
Mary Jo Fackler
Pang-Kuo Lo
Pedram Argani
Saraswati Sukumar
Tej K Pandita
Tsuyoshi Mori
Xiaohui Liang
P2860
P304
P356
10.1158/0008-5472.CAN-10-1576
P407
P577
2010-06-29T00:00:00Z